Thomas Malley Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

KNSA Quotes by TradingView

Thomas Malley is of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 12,546 shares of KNSA, which is worth approximately $370,357. The most recent transaction as insider was on Jun 05, 2025, when has been sold 3,173 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.5K
33.85% 3M change
33.85% 12M change
Total Value Held $370,357

Thomas Malley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2025
BUY
Exercise of conversion of derivative security
-
3,173 Added 20.19%
12,546 Class A Ordinary Shares
Jun 06 2024
BUY
Exercise of conversion of derivative security
-
4,373 Added 31.81%
9,373 Class A Common Shares
Jun 29 2023
BUY
Exercise of conversion of derivative security
-
5,000 Added 50.0%
5,000 Class A Common Shares

Also insider at

BGNE
BeiGene, Ltd. Healthcare
Director
KURA
Kura Oncology, Inc. Healthcare
TM

Thomas Malley

Camana Bay, Grand Cayman, E9

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KNSA